trending Market Intelligence /marketintelligence/en/news-insights/trending/o9keoxk79nabukgylcdn0a2 content esgSubNav
In This List

Oncobiologics CEO steps down; interim replacement named

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Oncobiologics CEO steps down; interim replacement named

Oncobiologics Inc. said its founder Pankaj Mohan stepped down from the positions of chairman and CEO, effective June 18.

The Cranbury, N.J.-based biopharmaceutical company said Mohan will remain a board member and will enter into a consulting agreement to provide advisory services in connection with the development of its product candidate ONS-5010.

Oncobiologics said board member Randy Thurman will assume the role of executive chairman and CFO Lawrence Kenyon will serve as interim CEO.

Thurman joined Oncobiologics' board in April, while Kenyon joined the company as CFO and corporate secretary in September 2015.

Oncobiologics' board has formed a search committee to find a permanent CEO.